228 related articles for article (PubMed ID: 12966627)
1. [On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].
Lamers CB
Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1630-2. PubMed ID: 12966627
[TBL] [Abstract][Full Text] [Related]
2. [As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].
Poen AC; Otten MH
Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1632-6. PubMed ID: 12966628
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
4. Treatment of gastroesophageal reflux disease.
Pettit M
Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
[TBL] [Abstract][Full Text] [Related]
5. On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerations.
Inadomi JM
Pharmacoeconomics; 2002; 20(9):565-76. PubMed ID: 12141885
[TBL] [Abstract][Full Text] [Related]
6. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
van Zanten SV
Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
[No Abstract] [Full Text] [Related]
7. On-demand therapy for gastro-oesophageal reflux disease.
Bytzer P
Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S19-22. PubMed ID: 11430504
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approaches to reflux disease, focusing on acid secretion.
Kinoshita Y; Adachi K; Fujishiro H
J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment of gastroesophageal reflux disease - beyond the proton pump inhibitors.
Holloway RH; Dent J
Dig Dis; 2000; 18(1):7-13. PubMed ID: 10729732
[No Abstract] [Full Text] [Related]
10. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
11. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological management of gastro-oesophageal reflux disease.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
[TBL] [Abstract][Full Text] [Related]
13. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
Garnett WR
Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
Storr M; Meining A; Allescher HD
Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061
[TBL] [Abstract][Full Text] [Related]
16. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
[TBL] [Abstract][Full Text] [Related]
17. Dyspepsia responsive to acid suppression therapy: reflux disease or duodenal hypersensitivity?
Smout AJ
Dig Liver Dis; 2000 Dec; 32 Suppl 3():S258-60. PubMed ID: 11245313
[No Abstract] [Full Text] [Related]
18. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
19. Trends in the management of gastro-oesophageal reflux disease.
Lee JM; O'Morain CA
Postgrad Med J; 1998 Mar; 74(869):145-50. PubMed ID: 9640439
[TBL] [Abstract][Full Text] [Related]
20. Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease.
Castell DO
Aliment Pharmacol Ther; 1991; 5 Suppl 1():59-67. PubMed ID: 1679673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
